Journal of Cancer Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Cancer Clinical Research 44 7897 074717

Nano Cancer

 

Cancer nanotechnology may be a branch of nanotechnology concerned with the appliance of both nanomaterials and nanotechnology approaches (such as nanoparticle-based theranostics) to the diagnosis and treatment of cancer.

Cancer therapies are currently limited to chemotherapy, surgery, and radiation. All three methods may cause damage to normal tissues or inappropriate eradication of the cancer. Nanotechnology offers the means to concentrate on chemotherapies selectively and directly to cancerous cells and neoplasms, act as guide in surgical resection of tumors, and increases the therapeutic efficacy of radiation-based and other current treatment modalities. All of this will add up to a decreased risk to the patient and an increased probability of survival.

Research on nanotechnology cancer therapy extends beyond drug delivery into the creation of latest therapeutics available only through use of nanomaterial properties. Although small compared to cells, nanoparticles are large enough to encapsulate many small molecule compounds, which may be of multiple types. At an equivalent time, the relatively large area of nanoparticle are often functionalized with ligands, including small molecules, DNA or RNA strands, peptides, aptamers or antibodies.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Get the App